Abstract:Secondary messengers (such as (p)ppGpp and c-di-GMP) were proved to play important roles in antibiotic biosynthesis in actinobacteria. In this study, we found that transcription levels of erythromycin-biosynthetic (ery) genes were upregulated in nutrient limitation, which depended on (p)ppGpp in Saccharopolyspora erythraea. Further study demonstrated that the expression of ery genes and intracellular concentrations of (p)ppGpp showed synchronization during culture process. The erythromycin yield was significantly improved (about 200%) by increasing intracellular concentration of (p)ppGpp through introduction of C-terminally truncated (p)ppGpp synthetase RelA (1.43 kb of the N-terminal segment) from Streptomyces coelicolor into S. erythraea strain NRRL2338 (named as WT/pIB-P-BAD-relA(1-489)). As the intracellular concentration of (p)ppGpp in an industrial erythromycin-high-producing strain E3 was greatly higher (about 10- to 100-fold) than WT strain, the applications of the above-described strategy did not work in E3 strain. Further research revealed that low concentration of 2-oxoglutarate in E3 strain exerted a nitrogen-rich pseudosignal, leading to the downregulation of nitrogen metabolism genes, which limited the use of nitrogen sources and thus the high intracellular (p)ppGpp concentration. Furthermore, the secondary messenger, c-di-GMP, was proved to be able to activate ery genes transcription by enhancing binding of BldD to promoters of ery genes. Overexpressing the diguanylate cyclase CdgB from S. coelicolor in S. erythraea increased the intracellular c-di-GMP concentration, and improved erythromycin production. These findings demonstrated that increasing the concentration of intracellular secondary messengers can activate ery genes transcription, and provided new strategies for designing metabolic engineering based on secondary messengers to improve antibiotics yield in actinobacteria.

Molecular biology on erythromycin biosynthesis

Biochemistry and Genetics of Erythromycin Biosynthesis

Biosynthesis and Genetic Engineering of Polyketides

Heterologous erythromycin production across strain and plasmid construction

Biosynthesis of C-nucleoside antibiotics in actinobacteria: recent advances and future developments

Systems Perspectives on Erythromycin Biosynthesis by Comparative Genomic and Transcriptomic Analyses of S. Erythraea E3 and NRRL23338 Strains

Natural and Engineered Biosynthesis of Nucleoside Antibiotics in Actinomycetes

Gene modifi cation of erythromycin-producing strain S.erytheara

From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Progress in the Research of Biosynthesis of Tetracyclines

Metabolic Engineering Strategies Based on Secondary Messengers (p)ppgpp and C-di-GMP to Increase Erythromycin Yield in Saccharopolyspora Erythraea.

Advance in the Research on Quinomycins Biosynthesis

Tailoring Pathway Modularity in the Biosynthesis of Erythromycin Analogs Heterologously Engineered in E. Coli

Broadened Glycosylation Patterning of Heterologously Produced Erythromycin

Biosynthesis and pathway engineering of antifungal polyene macrolides in actinomycetes

Identification and characterization of a new erythromycin biosynthetic gene cluster in Actinopolyspora erythraea YIM90600, a novel erythronolide-producing halophilic actinomycete isolated from salt field.

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics

Precursor supply for erythromycin biosynthesis: engineering of propionate assimilation pathway based on propionylation modification.

Biosynthesis and combinatorial biosynthesis of polyene macrolides antibiotics

Harnessing synthetic biology-based strategies for engineered biosynthesis of nucleoside natural products in actinobacteria